Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;68(12):2779-2796.
doi: 10.4103/ijo.IJO_2995_20.

Phakic intraocular lenses: An overview

Affiliations
Review

Phakic intraocular lenses: An overview

Soraya M R Jonker et al. Indian J Ophthalmol. 2020 Dec.

Abstract

Phakic intraocular lenses (pIOLs) are a common solution for the surgical correction of high myopia and myopia in thin corneas. Global trends result in increasing rates of patients with high myopia which will result in increased rates of pIOL implantation. Three types of lenses can be distinguished: anterior chamber angle-supported, anterior chamber iris-fixated, and posterior chamber phakic IOLs. The efficacy of phakic intraocular lenses is generally very good, but pIOLs have undergone many changes over the years to improve the safety profile and decrease pIOL-related complications such as endothelial cell loss, corneal decompensation and cataract formation. This article describes the efficacy and safety profiles of the most recent pIOLs, as well as suggests gaps of knowledge that are deserve additional research to optimize the results of pIOLs.

Keywords: High Myopia; Phakic Intraocular Lens; Refractive Surgery.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Surgical correction of refractive errors using laser refractive correction (top), phakic intraocular lens implantation (center), refractive lens exchange (bottom)
Figure 2
Figure 2
Three different phakic intraocular lenses: angle supported (left), iris-fixated (center), posterior chamber (right)

References

    1. WHO. World Health Organization Brien Holden Vision Institute; 2017. The Impact of Myopia and High Myopia.
    1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42. - PubMed
    1. Morgan IG, He M, Rose KA. Epidemic of pathologic myopia: What can laboratory studies and epidemiology tell us? Retina. 2017;37:989–97. - PubMed
    1. Azar DT, Azar NF, Brodie SE, Hoffer KJ, Korn TS, Mauger TF, et al. Clinical Optics United States of America: American Academy of Ophthalmology. 2017
    1. Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis. Ophthalmology. 2016;123:697–708. - PubMed